StockData
Vaxart, Inc. logo

Vaxart, Inc. (VXRT) stock

VXRTOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$0.48+0.02 (+5.04%)

Close on Oct 19, 2026Market cap $115.61MP/E 4.0Yield –

Vaxart statistics

44 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
Nov 9, 2012
Fundamentals through
Sep 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
5.54%
10.8%
Shares Change (QoQ)
0.36%
0.50%
Float
235M
49M
Shares Held by Insiders
3.25%
11.7%
Shares Held by Institutions
0.03%
56.4%

MarginsIndustry

Operating Margin
16.6%
-38.7%
Pretax Margin
16.4%
-11.6%
Profit Margin
16.0%
-31.6%
EBITDA Margin
19.5%
-27.7%
FCF Margin
17.6%
-9.56%

Returns on capitalIndustry

Return on Equity (ROE)
62.4%
-49.9%
Return on Assets (ROA)
16.3%
-40.6%
Return on Capital Employed (ROCE)
40.6%
-37.9%

Financial positionIndustry

Current Ratio
1.71
3.30
Quick Ratio
1.17
2.39

GrowthIndustry

Revenue Growth (YoY)
22.3%
6.82%
Revenue Growth (3Y CAGR)
1204.0%
2.25%
Revenue Growth (5Y CAGR)
125.8%
6.41%

EfficiencyIndustry

Asset Turnover
1.02
0.40
Revenue Per Employee
$2.79M
$429.29K
Profits Per Employee
$446.79K
-$689.41K
Employee Count
65
74

Income statement (TTM)Industry

Revenue
$181.27M
$66.37M
Operating Income
$30.14M
-$21.37M
Pretax Income
$29.76M
-$12.95M
Net Income
$29.04M
-$22.35M
EBITDA
$35.34M
-$17.21M
EPS (Diluted)
$0.12
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$65.50M
$17.76M
Net Cash Per Share
$0.27
$0.80
Equity (Book Value)
$66.29M
$53.89M
Book Value Per Share
$0.27
$1.50
Tangible Book Value
$59.51M
$27.13M
Working Capital
$52.50M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
$32.82M
-$12.38M
Capital Expenditures
-$855.00K
-$1.00M
Free Cash Flow
$31.97M
-$18.21M
FCF Per Share
$0.13
-$0.42

Taxes and interestIndustry

Income Tax
$714.00K
$73.00K
Effective Tax Rate
2.40%
20.9%

Scores and fair valueIndustry

Graham Number
$0.86
$19.34
Piotroski F-Score
6
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodVXRTS&P 500DifferenceVXRT per yearS&P 500 per year
1 month-2.2%+0.6%−2.8 pts
3 months-7.7%+3.4%−11.0 pts
Year to date+37.3%+13.3%+24.0 pts
1 year+32.1%+16.6%+15.5 pts
3 years-32.1%+86.4%−118.4 pts-12.1%+23.1%
5 years-93.3%+81.9%−175.1 pts-41.7%+12.7%
10 years-97.1%+318.9%−416.0 pts-29.9%+15.4%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

2M VXRT shares were sold short on Oct 30, 2026, up 0.5% from the previous report. At recent volumes it would take 4.0 days to buy them back. Over the last 20 sessions, 53.7% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20262,417,496+0.5%611,5864.0
Oct 15, 20262,404,459+3.3%495,2654.8
Sep 30, 20262,326,956+0.9%499,8394.7
Sep 15, 20262,306,655-0.2%517,6644.5
Aug 31, 20262,311,972-1.0%602,6093.8
Aug 14, 20262,334,259-5.1%432,8375.4
Jul 31, 20262,458,625-4.4%627,2633.9
Jul 15, 20262,571,609-0.5%603,7594.3
Jun 30, 20262,585,593-1.6%750,2593.5
Jun 15, 20262,627,832-1.1%625,5634.2
May 29, 20262,656,719-0.1%946,0612.8
May 15, 20262,660,202-9.0%962,8852.8

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?